Analysis of select members of the E26 (ETS) transcription factors family in colorectal cancer
- 12 February 2011
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 458 (4) , 421-430
Abstract
The E-twenty-six (ETS) family of transcription factors is known to act as positive or negative regulators of the expression of genes that are involved in diverse biological processes, including those that control cellular proliferation, differentiation, hematopoiesis, apoptosis, metastasis, tissue remodeling, and angiogenesis. Identification of target gene promoters of normal and oncogenic transcription factors provides new insights into the regulation of genes that are involved in the control of normal cell growth and differentiation. The aim of the present investigation was to analyze the differential expression of 11 ETS (ELF-3, ESE3, ETS1, ETV3, ETV4, ETV6, NERF, PDEF, PU1, Spi-B, and Spi-C) as potential markers for prognostic of colorectal cancer. A series of paired tissue biopsies consisting of a tumor and a non-affected control sample were harvested from 28 individuals suffering from diagnosed colorectal lesions. Total RNA was isolated from the samples, and after reverse transcription, differential expression of the select ETS was carried out through real-time polymerase chain reaction. Tumor staging as determined by histopathology was carried out to correlate the degree of tumor invasiveness with the expression of the ETS genes. The results demonstrated a different quantitative profile of expression in tumors and normal tissues. ETV4 was significantly upregulated with further increase in the event of lymph node involvement. PDEF and Spi-B presented downregulation, which was more significant when lymph node involvement was present. These findings were supported by immunohistochemistry of tumoral tissues. The results suggest that select ETS may serve as potential markers of colorectal cancer invasiveness and metastasis.Keywords
This publication has 36 references indexed in Scilit:
- RETRACTED ARTICLE: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEFMolecular Cancer, 2010
- The Ets factor Spi-B is a direct critical target of the coactivator OBF-1Proceedings of the National Academy of Sciences, 2006
- ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasionBiochemical and Biophysical Research Communications, 2006
- Transcription factors in cancerEuropean Journal of Cancer, 2005
- ETS transcription factors and their emerging roles in human cancerEuropean Journal of Cancer, 2005
- Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesisCarcinogenesis, 2005
- Ets proteins in biological control and cancerJournal of Cellular Biochemistry, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Ets target genes: past, present and futureOncogene, 2000
- Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancersInternational Journal of Cancer, 2000